(The Hill) — President Trump’s new pharmaceutical tariff policy throws another wrench into an already increasingly complex drug supply chain, with experts calling for more clarity and details on the ...
After the U.S. tariff imposition, policymakers must diversify boldly, reform swiftly, and secure India’s pharma supremacy ...
SINGAPORE (Reuters) -The implementation of a U.S. tariff on Singapore's pharmaceutical exports has been delayed to allow companies to negotiate possible exemptions with the U.S. administration, the ...
Looking back on 2025, a lot happened in the world of healthcare. This year was largely defined by the arrival of the second Trump administration, armed with tariff threats, unorthodox views about ...
Johnson & Johnson joins TrumpRx to lower US drug prices, receiving tariff exemptions in return, showcasing public-private collaboration benefits. TrumpRx now includes 15 major pharmaceutical companies ...
At the onset of this month, the UK and U.S. governments signed a landmark pharmaceuticals trade deal aimed at rebalancing transatlantic commerce and securing access to innovative medicines. The core ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback